Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease

Background/Aims: Nonalcoholic fatty liver disease (NAFLD) encompasses a range of diseases from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) and has been linked to cardiovascular disease and sub-clinical cardiac remodeling. This paper presents a retrospective study of biop...

Full description

Bibliographic Details
Main Authors: Peter C. Johnson, Anthony A. Cochet, Rosco S. Gore, Stephen A. Harrison, John P. Magulick, James K. Aden, Angelo H.Paredes
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2022-09-01
Series:The Korean Journal of Gastroenterology
Subjects:
Online Access:https://www.kjg.or.kr/journal/view.html?uid=5745&vmd=Full
_version_ 1818017282546204672
author Peter C. Johnson
Anthony A. Cochet
Rosco S. Gore
Stephen A. Harrison
John P. Magulick
James K. Aden
Angelo H.Paredes
author_facet Peter C. Johnson
Anthony A. Cochet
Rosco S. Gore
Stephen A. Harrison
John P. Magulick
James K. Aden
Angelo H.Paredes
author_sort Peter C. Johnson
collection DOAJ
description Background/Aims: Nonalcoholic fatty liver disease (NAFLD) encompasses a range of diseases from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) and has been linked to cardiovascular disease and sub-clinical cardiac remodeling. This paper presents a retrospective study of biopsy-proven NAFL and NASH to examine the differences in subclinical cardiac remodeling. Methods: Patients were recruited from an institutional repository of patients with liver-biopsy-confirmed NAFLD. Patients with a transthoracic echocardiogram (TTE) within 12 months of the liver biopsy were included. The parameters of the diastolic dysfunction were reviewed for the differences between NAFL and NASH as well as between the stages and grades of NASH. Results: Thirty-three patients were included in the study, 17 with NAFL and 16 with NASH. The NASH patients were more likely to have lower platelets, higher AST, higher ALT, and higher rates of type 2 diabetes mellitus, coronary artery disease, and hypertension than the NAFL patients. The E/e’ ratio on transthoracic echocardiogram was significantly higher in NASH compared to NAFL, advanced-stage NASH compared to early stage, and high-grade NASH compared to low-grade. The E/e’ ratio was also significantly higher in NASH than NAFL in patients without diabetes mellitus. The presence of diastolic dysfunction trended toward significance. The other markers of diastolic dysfunction were similar. Logistic regression revealed a statistical association with E/e' and NASH. Conclusions: NASH patients had evidence of a higher E/e’ ratio than NAFL, and there was a trend towards a significant diastolic dysfunction. Patients with NASH compared to NAFL should be closely monitored for signs and symptoms of cardiac dysfunction.
first_indexed 2024-04-14T07:24:08Z
format Article
id doaj.art-081ce2e5b28d411ca9db977ee170c3a4
institution Directory Open Access Journal
issn 1598-9992
2233-6869
language English
last_indexed 2024-04-14T07:24:08Z
publishDate 2022-09-01
publisher Jin Publishing & Printing Co.
record_format Article
series The Korean Journal of Gastroenterology
spelling doaj.art-081ce2e5b28d411ca9db977ee170c3a42022-12-22T02:06:03ZengJin Publishing & Printing Co.The Korean Journal of Gastroenterology1598-99922233-68692022-09-0178316116710.4166/kjg.2021.040Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver DiseasePeter C. Johnson0https://orcid.org/0000-0003-4466-3052Anthony A. Cochet1Rosco S. Gore2Stephen A. Harrison3John P. Magulick4James K. Aden5Angelo H.Paredes6Department of Medicine, Brooke Army Medical Center, San Antonio, TX; Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD, USADepartment of Medicine, Cardiology Service, Brooke Army Medical Center3, San Antonio, TX, USADepartment of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD; Department of Medicine, Cardiology Service, Brooke Army Medical Center, San Antonio, TX, USAPinnacle Clinical Research, San Antonio, TX, USADepartment of Medicine, Gastroenterology and Hepatology Service, Brooke Army Medical Center, TX, USADepartment of Medicine, US Army Institute for Surgical Research, San Antonio, TX, USADepartment of Medicine, Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD; Department of Medicine, Cardiology Service, Brooke Army Medical Center, San Antonio, TX, USABackground/Aims: Nonalcoholic fatty liver disease (NAFLD) encompasses a range of diseases from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) and has been linked to cardiovascular disease and sub-clinical cardiac remodeling. This paper presents a retrospective study of biopsy-proven NAFL and NASH to examine the differences in subclinical cardiac remodeling. Methods: Patients were recruited from an institutional repository of patients with liver-biopsy-confirmed NAFLD. Patients with a transthoracic echocardiogram (TTE) within 12 months of the liver biopsy were included. The parameters of the diastolic dysfunction were reviewed for the differences between NAFL and NASH as well as between the stages and grades of NASH. Results: Thirty-three patients were included in the study, 17 with NAFL and 16 with NASH. The NASH patients were more likely to have lower platelets, higher AST, higher ALT, and higher rates of type 2 diabetes mellitus, coronary artery disease, and hypertension than the NAFL patients. The E/e’ ratio on transthoracic echocardiogram was significantly higher in NASH compared to NAFL, advanced-stage NASH compared to early stage, and high-grade NASH compared to low-grade. The E/e’ ratio was also significantly higher in NASH than NAFL in patients without diabetes mellitus. The presence of diastolic dysfunction trended toward significance. The other markers of diastolic dysfunction were similar. Logistic regression revealed a statistical association with E/e' and NASH. Conclusions: NASH patients had evidence of a higher E/e’ ratio than NAFL, and there was a trend towards a significant diastolic dysfunction. Patients with NASH compared to NAFL should be closely monitored for signs and symptoms of cardiac dysfunction.https://www.kjg.or.kr/journal/view.html?uid=5745&vmd=Fullnon-alcoholic fatty liver diseasesteatohepatitisdiastolic heart failurecardiac diseases
spellingShingle Peter C. Johnson
Anthony A. Cochet
Rosco S. Gore
Stephen A. Harrison
John P. Magulick
James K. Aden
Angelo H.Paredes
Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease
The Korean Journal of Gastroenterology
non-alcoholic fatty liver disease
steatohepatitis
diastolic heart failure
cardiac diseases
title Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease
title_full Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease
title_fullStr Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease
title_full_unstemmed Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease
title_short Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease
title_sort early cardiac dysfunction in biopsy proven nonalcoholic fatty liver disease
topic non-alcoholic fatty liver disease
steatohepatitis
diastolic heart failure
cardiac diseases
url https://www.kjg.or.kr/journal/view.html?uid=5745&vmd=Full
work_keys_str_mv AT petercjohnson earlycardiacdysfunctioninbiopsyprovennonalcoholicfattyliverdisease
AT anthonyacochet earlycardiacdysfunctioninbiopsyprovennonalcoholicfattyliverdisease
AT roscosgore earlycardiacdysfunctioninbiopsyprovennonalcoholicfattyliverdisease
AT stephenaharrison earlycardiacdysfunctioninbiopsyprovennonalcoholicfattyliverdisease
AT johnpmagulick earlycardiacdysfunctioninbiopsyprovennonalcoholicfattyliverdisease
AT jameskaden earlycardiacdysfunctioninbiopsyprovennonalcoholicfattyliverdisease
AT angelohparedes earlycardiacdysfunctioninbiopsyprovennonalcoholicfattyliverdisease